IFNG and myocarditis: In a TCR transgenic mouse model with spontaneous autoimmune myocarditis progressing into DCM, blocking IFN-γ signaling significantly attenuated myocarditis without affecting the development of DCM, while lack of IL-17A inhibited DCM but had a mild effect on myocarditis (54).